Inverse Vaccine Nanomimics: In situ Antigen-Specific Immune Tolerance Induction for Durable Cardiac Repair Post-Myocardial Infarction.
- 1Department of Cardiology, The Third People's Hospital of Chengdu/Affiliated Hospital of Southwest Jiaotong University, Chengdu Institute of Cardiovascular Disease, Chengdu, China.
- 2School of Ecology and Environment, Xizang University, Lhasa, China.
- 3The Tenth Affiliated Hospital, Southern Medical University (Dongguan People's Hospital), Dongguan, China.
Abstract
Alleviating the inflammatory response by inducing immune tolerance to cardiomyocyte lysate antigens has been shown to be a promising therapeutic approach for treating myocardial infarction (MI). However, immune tolerance induced by allogeneic antigens is constrained by insufficient antigen specificity, safety risks, and transient therapeutic efficacy. Herein, we present an injectable hydrogel capable of environment-responsive, long-acting delivery of inverse vaccine nanomimics (IVNMs) to overcome these challenges. These IVNMs efficiently capture antigens released by dying cardiomyocytes through the orthogonal reaction between surface maleimide groups and antigen thiols and promote mannose-facilitated uptake by CD206-expressing immune cells, including dendritic cells (DCs). The antigens captured by IVNMs, together with the sustained release of rapamycin from IVNMs, promote the differentiation of DCs into tolerogenic DCs, leading to a persistent increase in regulatory T cells and the establishment of immune tolerance memory. In post-MI rat models, myocardial inflammation was markedly and persistently alleviated, accompanied by enhanced neovascularization and reduced fibrosis, contributing to a sustained cardioprotective effect.
Related
- Impact of obesity on tolerance and persistence of statins in patients within 3 months following an acute myocardial infarction: A real-world study
- ECG-Derived Synthetic Left Ventricular Mechanics Predict Mortality After Acute Myocardial Infarction and Fatal Myocardial Infarction in the General Population
- Beta-Blocker Therapy After Acute Myocardial Infarction
- The Korea Acute Myocardial Infarction Registry: Two Decades of AMI Care in Korea.
- Role of Inflammation in the Development of Heart Failure After Myocardial Infarction
BibTeX
@article{yue2026inverse,
title = {{Inverse Vaccine Nanomimics: In situ Antigen-Specific Immune Tolerance Induction for Durable Cardiac Repair Post-Myocardial Infarction.}},
author = {Tian Yue and Jiali Yang and Qing Ma and Jian He and Ying Wang and Zhilu Yang and Jun Hou},
journal = {Research (Washington, D.C.)},
year = {2026},
month = oct,
doi = {10.34133/research.1464},
url = {https://europepmc.org/article/MED/42909153},
note = {CC BY},
}
RIS
TY - JOUR
TI - Inverse Vaccine Nanomimics: In situ Antigen-Specific Immune Tolerance Induction for Durable Cardiac Repair Post-Myocardial Infarction.
AU - Tian Yue
AU - Jiali Yang
AU - Qing Ma
AU - Jian He
AU - Ying Wang
AU - Zhilu Yang
AU - Jun Hou
PY - 2026
DA - 2026/10/21
JO - Research (Washington, D.C.)
DO - 10.34133/research.1464
UR - https://europepmc.org/article/MED/42909153
AB - Alleviating the inflammatory response by inducing immune tolerance to cardiomyocyte lysate antigens has been shown to be a promising therapeutic approach for treating myocardial infarction (MI). However, immune tolerance induced by allogeneic antigens is constrained by insufficient antigen specificity, safety risks, and transient therapeutic efficacy. Herein, we present an injectable hydrogel capable of environment-responsive, long-acting delivery of inverse vaccine nanomimics (IVNMs) to overcome these challenges. These IVNMs efficiently capture antigens released by dying cardiomyocytes through the orthogonal reaction between surface maleimide groups and antigen thiols and promote mannose-facilitated uptake by CD206-expressing immune cells, including dendritic cells (DCs). The antigens captured by IVNMs, together with the sustained release of rapamycin from IVNMs, promote the differentiation of DCs into tolerogenic DCs, leading to a persistent increase in regulatory T cells and the establishment of immune tolerance memory. In post-MI rat models, myocardial inflammation was markedly and persistently alleviated, accompanied by enhanced neovascularization and reduced fibrosis, contributing to a sustained cardioprotective effect.
SN - 2639-5274
ER -